Multiplexed magnetic beads-assisted amperometric bioplatforms for global detection of methylations in nucleic acids.

5-Hydroxymethylcytosine 5-Methylcytosine DNA N6-methyladenine Electrochemical multiplexed bioplatforms Global methylation RNA N6-methyladenosine

Journal

Analytica chimica acta
ISSN: 1873-4324
Titre abrégé: Anal Chim Acta
Pays: Netherlands
ID NLM: 0370534

Informations de publication

Date de publication:
16 Oct 2021
Historique:
received: 27 05 2021
revised: 22 07 2021
accepted: 11 08 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 6 10 2021
Statut: ppublish

Résumé

This work reports the first electrochemical bioplatform developed for the multidetection of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in DNA, DNA N6-methyladenine (6mA) and RNA N6-methyladenosine (m6A) methylations at global level. Direct competitive immunoassays were implemented on the surface of magnetic beads (MBs) and optimized for the single amperometric determination of different targets varying in length, sequence and number of methylations on screen-printed carbon electrodes. After evaluating the sensitivity and selectivity of such determinations and the confirmation of no cross-reactivity, a multiplexed disposable platform allowing the simultaneous determination of the mentioned four methylation events in only 45 min has been prepared. The multiplexed bioplatform was successfully applied to the determination of m6A in cellular total RNA and of 5-mC, 5-hmC and 6mA in genomic DNA extracted from tissues. The developed bioplatform showed its usefulness to discriminate the aggressiveness of cancerous cells and between healthy and tumor tissues of colorectal cancer patients.

Identifiants

pubmed: 34602192
pii: S0003-2670(21)00772-8
doi: 10.1016/j.aca.2021.338946
pii:
doi:

Substances chimiques

Nucleic Acids 0
RNA 63231-63-0
Adenosine K72T3FS567

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338946

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eloy Povedano (E)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

Maria Gamella (M)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

Rebeca M Torrente-Rodríguez (RM)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

Víctor Ruiz-Valdepeñas Montiel (V)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

Ana Montero-Calle (A)

Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220, Madrid, Spain.

Guillermo Solís-Fernández (G)

Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220, Madrid, Spain.

Fernando Navarro-Villoslada (F)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

María Pedrero (M)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.

Alberto Peláez-García (A)

Department of Pathology, Hospital Universitario La Paz, IdiPAZ, 28046, Madrid, Spain.

Marta Mendiola (M)

Department of Pathology, Hospital Universitario La Paz, IdiPAZ, 28046, Madrid, Spain; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)), Instituto de Salud Carlos III, 28029, Madrid, Spain.

David Hardisson (D)

Department of Pathology, Hospital Universitario La Paz, IdiPAZ, 28046, Madrid, Spain; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)), Instituto de Salud Carlos III, 28029, Madrid, Spain; Faculty of Medicine, Universidad Autónoma de Madrid, 28029, Madrid, Spain.

Jaime Feliú (J)

Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)), Instituto de Salud Carlos III, 28029, Madrid, Spain; Translational Oncology Group Hospital Universitario La Paz IdiPAZ, 28046, Madrid, Spain.

Rodrigo Barderas (R)

Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220, Madrid, Spain. Electronic address: r.barderasm@isciii.es.

José M Pingarrón (JM)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain. Electronic address: pingarro@quim.ucm.es.

Susana Campuzano (S)

Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain. Electronic address: susanacr@quim.ucm.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH